Insider · CIK 0001252522

Galakatos Nicholas

CIK 0001252522 Name as filed on the most recent filing

Filed as Galakatos Nicholas (124)

215 transaction lines · from 124 filings · filed 2004-02-23 to 2018-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

32 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-09-28 P, Open-market purchase Entasis Therapeutics Holdings Inc.ETTX 6,800,925, acquired Open Form 4 filing 0001209191-18-053536
2018-09-17 S, Open-market sale NanoString Technologies IncNSTG 1,372,310, disposed Open Form 4 filing 0001401708-18-000121
2018-07-02 P, Open-market purchase Forty Seven, Inc.FTSV 3,200,000, acquired Open Form 4 filing 0001209191-18-040426
2016-02-09 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 36,881, disposed Open Form 4 filing 0001012975-16-000991
2016-02-08 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 19,593, disposed Open Form 4 filing 0001012975-16-000991
2016-02-05 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 166,576, disposed Open Form 4 filing 0001012975-16-000980
2016-02-04 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 70,004, disposed Open Form 4 filing 0001012975-16-000980
2016-02-03 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 12,387, disposed Open Form 4 filing 0001012975-16-000980
2016-02-02 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 29,972, disposed Open Form 4 filing 0001012975-16-000957
2016-02-01 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 28,000, disposed Open Form 4 filing 0001012975-16-000957
2016-01-29 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 13,735, disposed Open Form 4 filing 0001012975-16-000957
2016-01-28 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 8,455, disposed Open Form 4 filing 0001012975-16-000938
2016-01-27 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 56,696, disposed Open Form 4 filing 0001012975-16-000938
2016-01-26 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 20,828, disposed Open Form 4 filing 0001012975-16-000938
2016-01-11 S, Open-market sale Ophthotech Corp.OPHT 4 lines 197,171, disposed Open Form 4 filing 0001104659-16-089676
2015-12-10 S, Open-market sale Ophthotech Corp.OPHT 4 lines 193,309, disposed Open Form 4 filing 0001104659-15-084747
2015-11-18 S, Open-market sale Ophthotech Corp.OPHT 2 lines 90,000, disposed Open Form 4 filing 0001104659-15-080280
2015-11-10 S, Open-market sale Ophthotech Corp.OPHT 2 lines 88,035, disposed Open Form 4 filing 0001104659-15-078363
2015-11-09 S, Open-market sale Ophthotech Corp.OPHT 2 lines 90,000, disposed Open Form 4 filing 0001104659-15-078363
2015-11-02 S, Open-market sale Ophthotech Corp.OPHT 2 lines 81,000, disposed Open Form 4 filing 0001104659-15-075825
2015-06-30 P, Open-market purchase Catabasis Pharmaceuticals IncCATB 4,520,340, acquired Open Form 4 filing 0001104659-15-049022
2015-06-16 S, Open-market sale Oxford Immunotec Global PLCOXFD 567,724, disposed Open Form 4 filing 0001012975-15-000491
2015-06-15 S, Open-market sale Oxford Immunotec Global PLCOXFD 21,819, disposed Open Form 4 filing 0001012975-15-000491
2015-06-12 S, Open-market sale Oxford Immunotec Global PLCOXFD 91,628, disposed Open Form 4 filing 0001012975-15-000485
2015-06-11 S, Open-market sale Oxford Immunotec Global PLCOXFD 359,147, disposed Open Form 4 filing 0001012975-15-000485
2015-06-10 S, Open-market sale Oxford Immunotec Global PLCOXFD 128,694, disposed Open Form 4 filing 0001012975-15-000479
2015-06-09 S, Open-market sale Oxford Immunotec Global PLCOXFD 185,380, disposed Open Form 4 filing 0001012975-15-000479
2015-06-08 S, Open-market sale Oxford Immunotec Global PLCOXFD 37,934, disposed Open Form 4 filing 0001012975-15-000479
2015-06-03 S, Open-market sale Oxford Immunotec Global PLCOXFD 149,644, disposed Open Form 4 filing 0001012975-15-000473
2015-06-02 S, Open-market sale Oxford Immunotec Global PLCOXFD 156,950, disposed Open Form 4 filing 0001012975-15-000473
2015-06-01 S, Open-market sale Oxford Immunotec Global PLCOXFD 214,493, disposed Open Form 4 filing 0001012975-15-000473
2015-03-23 S, Open-market sale Oxford Immunotec Global PLCOXFD 379,772, disposed Open Form 4 filing 0001012975-15-000242
2015-03-20 S, Open-market sale Oxford Immunotec Global PLCOXFD 393,981, disposed Open Form 4 filing 0001012975-15-000242
2015-03-19 S, Open-market sale Oxford Immunotec Global PLCOXFD 730,675, disposed Open Form 4 filing 0001012975-15-000238
2015-03-18 S, Open-market sale Oxford Immunotec Global PLCOXFD 367,000, disposed Open Form 4 filing 0001012975-15-000238
2015-03-17 S, Open-market sale Oxford Immunotec Global PLCOXFD 1,163,434, disposed Open Form 4 filing 0001012975-15-000238
2015-01-08 S, Open-market sale Aerie Pharmaceuticals IncAERI 5,444,250, disposed Open Form 4 filing 0001012975-15-000017
2015-01-05 S, Open-market sale Aerie Pharmaceuticals IncAERI 2 lines 728,913, disposed Open Form 4 filing 0001012975-15-000003
2014-12-29 S, Open-market sale Aerie Pharmaceuticals IncAERI 186,606, disposed Open Form 4 filing 0001012975-14-000835

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 7
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GALAKATOS NICHOLAS, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001252522

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.